1-Naphthyl 3,5-dinitrobenzoate has been identified as a dual 5-lipoxygenase and microsomal prostaglandin E synthase-1 inhibitor with IC values of 1 and 3.6 µM, respectively. The scaffold of this compound is being explored for anti-inflammatory drug design.